• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

房室结内传导和心脏再同步治疗。

Atrioventricular intrinsic conduction and cardiac resynchronization therapy.

机构信息

Department of Cardiology, Affiliated Hospital of Nanjing Medical University in Wuxi and Wuxi People's Hospital, Wuxi, Jiangsu 214023, China.

出版信息

Chin Med J (Engl). 2011 Feb;124(3):436-9.

PMID:21362347
Abstract

Cardiac resynchronization therapy (CRT) is a major breakthrough in therapy for patients with advanced congestive heart failure, however, a number of key clinical research questions remain, perhaps most importantly the issue of why apparently suitable patients do not respond to CRT. These issues are also relevant to patients who do respond to CRT as potentially their response might be further increased. Though patients do not respond to CRT because of many known postulated reasons, we review the importance of maintaining atrioventricular intrinsic conduction during CRT in this paper, which maybe is one of methods to reduce the rates of non-response to CRT.

摘要

心脏再同步治疗(CRT)是治疗晚期充血性心力衰竭患者的重大突破,然而,仍有许多关键的临床研究问题悬而未决,也许最重要的问题是为什么显然适合的患者对 CRT 没有反应。这些问题也与对 CRT 有反应的患者有关,因为他们的反应可能进一步增加。虽然由于许多已知的推测原因,患者对 CRT 没有反应,但我们在本文中回顾了在 CRT 期间保持房室内在传导的重要性,这可能是降低 CRT 无反应率的方法之一。

相似文献

1
Atrioventricular intrinsic conduction and cardiac resynchronization therapy.房室结内传导和心脏再同步治疗。
Chin Med J (Engl). 2011 Feb;124(3):436-9.
2
Initial experiences of maintaining atrioventricular intrinsic conduction during cardiac resynchronization therapy in non-responders.非反应者心脏再同步治疗中维持房室内在传导的初步经验。
Chin Med J (Engl). 2009 Oct 20;122(20):2455-60.
3
Cardiac resynchronization therapy: expanding clinical indications and refining patient selection.心脏再同步治疗:扩大临床适应证和优化患者选择。
Curr Opin Cardiol. 2012 Mar;27(2):137-42. doi: 10.1097/HCO.0b013e32834febd3.
4
Interatrial conduction correlates with optimal atrioventricular timing in cardiac resynchronization therapy devices.房间传导与心脏再同步治疗设备中的最佳房室间期相关。
Pacing Clin Electrophysiol. 2011 Apr;34(4):443-9. doi: 10.1111/j.1540-8159.2010.02988.x. Epub 2011 Jan 5.
5
Antiarrhythmic effect of reverse electrical remodeling associated with cardiac resynchronization therapy.心脏再同步治疗相关的逆向电重构的抗心律失常作用
Pacing Clin Electrophysiol. 2011 Mar;34(3):357-64. doi: 10.1111/j.1540-8159.2010.02974.x. Epub 2010 Nov 22.
6
Benefits, unresolved questions, and technical issues of cardiac resynchronization therapy for heart failure.心力衰竭心脏再同步治疗的益处、未解决的问题及技术问题
Am J Cardiol. 2005 Sep 1;96(5):710-7. doi: 10.1016/j.amjcard.2005.04.050.
7
Should we optimize cardiac resynchronization therapy during exercise?我们是否应该在运动过程中优化心脏再同步治疗?
J Cardiovasc Electrophysiol. 2010 Nov;21(11):1307-16. doi: 10.1111/j.1540-8167.2010.01815.x.
8
Feasibility, safety, and mid-term efficacy of cardiac resynchronization therapy in patients with severe heart failure and ventricular conduction delay: Chulalongkorn experience.心脏再同步治疗对重度心力衰竭合并心室传导延迟患者的可行性、安全性及中期疗效:朱拉隆功医院的经验
J Med Assoc Thai. 2007 Jul;90(7):1458-66.
9
The problem of non-response to cardiac resynchronization therapy.心脏再同步治疗无反应的问题。
Curr Opin Cardiol. 2006 Jan;21(1):20-6. doi: 10.1097/01.hco.0000198983.93755.99.
10
Effects of cardiac resynchronization therapy on disease progression in patients with congestive heart failure.心脏再同步治疗对充血性心力衰竭患者疾病进展的影响。
Ital Heart J. 2004 May;5(5):364-70.

引用本文的文献

1
Left Univentricular Pacing by Rate-Adaptive Atrioventricular Delay in Treatment of Chronic Heart Failure.左心室单腔起搏的房室延迟率适应性治疗慢性心力衰竭。
Med Sci Monit. 2017 Aug 17;23:3971-3980. doi: 10.12659/msm.904348.